We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
-4.31%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$22.5M
Cap. Flow
-$16.3M
Cap. Flow %
-13.63%
Top 10 Hldgs %
66.31%
Holding
29
New
1
Increased
2
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
MTN icon
Vail Resorts
MTN
+$6.44M
2
EL icon
Estee Lauder
EL
+$6.32M
3
CMP icon
Compass Minerals
CMP
+$1.24M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.51%
2 Real Estate 9.31%
3 Materials 5.66%
4 Consumer Staples 5.03%
5 Industrials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWY icon
26
iShares MSCI South Korea ETF
EWY
$28B
$1.03M 0.86%
20,155
NML
27
Neuberger Energy Infrastructure and Income Fund Inc
NML
$597M
$1.02M 0.86%
115,872
AVB
28
DELISTED
AvalonBay Communities
AVB
$428K 0.36%
1,947
-14,383
-88% -$3.25M
EPAM icon
29
EPAM Systems
EPAM
$5.59B
-10,000
Closed -$1.99M

Similar funds

Michelson Medical Research Foundation's Q4 2024 Portfolio in Review

As of Q4 2024, Michelson Medical Research Foundation held 29 positions worth $119M, down 16% from $142M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Michelson Medical Research Foundation withdrew a net $16.3M in Q4 2024, closing 1 position and reducing 7 holdings. Its most notable exit was EPAM Systems, an estimated $1.99M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 6.1% a quarter earlier, followed by Real Estate and Materials.

Against the trend, Michelson Medical Research Foundation opened a new position in Estee Lauder worth $6M.

  • Michelson Medical Research Foundation's largest Q4 2024 buy was Estee Lauder: 80,000 shares worth $6M.
  • Michelson Medical Research Foundation added most to Vail Resorts in Q4 2024, an estimated $6.44M increase.
  • Michelson Medical Research Foundation's biggest Q4 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $10.2M.
  • Michelson Medical Research Foundation fully exited EPAM Systems in Q4 2024, selling an estimated $1.99M.
  • Michelson Medical Research Foundation's ten largest holdings make up 66% of its $119M portfolio in Q4 2024.
  • Michelson Medical Research Foundation opened 1 new position and closed 1 in Q4 2024.
  • Michelson Medical Research Foundation's portfolio value fell 16% quarter-over-quarter to $119M.

Based on Michelson Medical Research Foundation's 13F filing for Q4 2024, filed 14 Feb 2025.